Jane Street
AUTL

Jane Street’s Autolus Therapeutics AUTL Stock Holding History

Jane Street’s Portfolio AUTL Stock Details AUTL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$480K Buy
299,862
+54,077
+22% +$84.8K ﹤0.01% 8123
2026
Q1 		$339K Sell
245,785
-435,215
-64% -$661K ﹤0.01% 8956
2025
Q4 		$1.36M Sell
681,000
-193,474
-22% -$297K ﹤0.01% 5531
2025
Q3 		$1.43M Buy
+874,474
New +$1.71M ﹤0.01% 5572
2025
Q2 		– Sell
-102,493
Closed -$159K – 9582
2025
Q1 		$159K Buy
102,493
+91,222
+809% +$185K ﹤0.01% 8596
2024
Q4 		$26.5K Buy
+11,271
New +$38.1K ﹤0.01% 9098
2024
Q3 		– Sell
-93,275
Closed -$325K – 9549
2024
Q2 		$325K Buy
93,275
+17,631
+23% +$76.1K ﹤0.01% 7683
2024
Q1 		$483K Buy
75,644
+8,149
+12% +$50.8K ﹤0.01% 6734
2023
Q4 		$435K Buy
67,495
+53,503
+382% +$204K ﹤0.01% 7001
2023
Q3 		$32.6K Sell
13,992
-9,273
-40% -$26.4K ﹤0.01% 8233
2023
Q2 		$55.4K Sell
23,265
-72,611
-76% -$172K ﹤0.01% 8186
2023
Q1 		$176K Buy
+95,876
New +$187K ﹤0.01% 7925
2022
Q4 		– Sell
-19,289
Closed -$41K – 9104
2022
Q3 		$41K Buy
19,289
+4,572
+31% +$13.5K ﹤0.01% 9001
2022
Q2 		$42K Buy
+14,717
New +$44.8K ﹤0.01% 8973
2022
Q1 		– Sell
-13,352
Closed -$69K – 10250
2021
Q4 		$69K Buy
+13,352
New +$80.1K ﹤0.01% 9399
2021
Q3 		– Sell
-29,588
Closed -$196K – 9894
2021
Q2 		$196K Buy
+29,588
New +$184K ﹤0.01% 8845
2020
Q3 		– Sell
-13,590
Closed -$218K – 7122
2020
Q2 		$218K Buy
+13,590
New +$151K ﹤0.01% 6258

Other funds holding AUTL

MCO
MAK Capital One New York $714M AUM 68.07% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return
SP
Syncona Portfolio St Peter Port, Guernsey $26.6M AUM 10.36% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
TAM
TFG Asset Management Grand Cayman, Cayman Islands $635M AUM 28.07% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jane Street's AUTL Position: Q2 2026 in Review

Jane Street increased its Autolus Therapeutics (AUTL) stake by 22% in Q2 2026, buying an estimated $84.8K and bringing the position to 299,862 shares worth $480K. The position accounts for ﹤0.01% of the portfolio, ranked #8123.

Jane Street first reported a position in AUTL in Q2 2020 and has held it in 17 quarters since. The position peaked at $1.43M in Q3 2025. 84 funds tracked by Wall St. Rank hold AUTL as of Q2 2026.

  • Jane Street held 299,862 shares of Autolus Therapeutics worth $480K as of Q2 2026.
  • Jane Street bought 54,077 Autolus Therapeutics shares in Q2 2026, an estimated $84.8K.
  • Autolus Therapeutics made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #8123 holding.
  • Jane Street first reported a position in Autolus Therapeutics in Q2 2020 and has held it in 17 quarters since.
  • Jane Street's Autolus Therapeutics position peaked at $1.43M in Q3 2025.
  • 84 funds tracked by Wall St. Rank held Autolus Therapeutics as of Q2 2026.

Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.